Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia

Chinese Medical Journal

Volumn 119, Issue 7, 2006, Pages 557-563

  Chen, Ruo Han ^a   Chen, Ke Ping ^a   Wang, Fang Zheng ^a   Hua, Wei ^a   Chen, Xin ^a   Zhang, Shu ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardioversion; Implantable cardioverter defibrillator; Inappropriate detection; Inappropriate therapy; Ventricular tachyarrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVULSIVE THERAPY; DEFIBRILLATOR; ELECTROMAGNETIC FIELD; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART MUSCLE POTENTIAL; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; IMPLANTATION; INCIDENCE; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MALE; ELECTROCARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 33646824338     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200604010-00006     Document Type: Article

References (22)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl Med 1997; 337: 1576-1583.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden cardiac death in patients with coronary artery disease. N Engl Med 1999; 341: 1882-1890.
3. Korte T, Jung W, Spehl S, Wolpert C, Moosdorf R, Manz M, et al. Incidence of ICD lead system related complications during long-term follow-up: Comparison of epicardial and endocardial electrode system. PACE 1995; 18: 2053-2061.
4. Korte T, Jung W, Ostermann G, Wolpert C, Spehl S, Esmailzadeh B, et al. Hospital readmission after transvenous cardioverter/defibrillator implantation: A single center study. Eur Heart J 2000; 21: 1186-1196.
5. Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl K, Haffajee CJ, et al. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 2001; 12: 521-528.
6. Korte T, Niehaus M, Meyer O, Tebbenjohanns J. Prospective evaluation of catheter ablation in patients with implantable cardioverter defibrillators and multiple inappropriate ICD therapies due to atrial fibrillation and type I atrial flutter. PACE 2001; 24: 1061-1066.
7. Wang FZ, Zhang S, Ren ZW, Guo JH, Hu DY, Chen X. On behalf of the working Group on ICD of the Chinese Society of Pacing an Electrophysiology. Indication of implantable cardioverter defibbrillatior therapy. Chin J Cardiac Arrhyth (Chin)2002; 6: 198-206.
8. Swerdlow C. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation 2001; 103: 2159-2164.
9. Hook BG, Callans DJ, Kleiman RB, Flores BT, Marchlinski FE. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Rhythm diagnosis and management aided by stored electrogram analysis. Circulation 1993; 87: 1897-1906.
10. Hook BG, Machlinski FE. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. J Am Coll Cardiol 1991; 17: 985-990.
11. Olson WH, Bardy GH, Mehra R. Onset and stability of ventricular tachyarrhythmia detection in an implantable pacer-cardioverter-defibrillator. Comp Cardiol 1987; 14:167-170.
12. Green UB, Garg A, Al-Kandari F, Ungab G, Tone L, Feld GK. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing. Interv Card Electrophysiol 2003;8: 71-75.
13. Swerdlow CD. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: State-of-the-art review. J Cardiovasec Electrophysiol 2001;12:606-612.
14. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, et al. Limitations and late complications of third generation automatic cardioverter-defibrillators. Circulation 1995; 91:2204-2213.
15. Weber M, Block M, Brunn J, Bansch D, Bocker D, Hammel D, et al. Inappropriate ICD-therapies: Incidence, causes, risk factors and prevention. Z Kardiol 1996; 85: 809-819.
16. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001;12: 134-142.
17. Kuhlkamp V, Domberger V, Mewis C, Suchalla R, Bosch RF, Seipel L. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999;10:905-915.
18. Swerdlow CD, Davie S, Kass RM, Chen PS, Hwang C, Mandel WJ, et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994; 23: 1342-1355.
19. Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994; 23: 1342-1355.
20. Korte T, Trappe HJ, Gronefeld G, Schulte B, Wolpert C, Meesmann M, et al. New ICD morphology criterion for differentiation of supraventricular and ventricular tachycardia. Z Kardiol 2000; 89: 1019-1025.
21. Neuzner J, Pitschner HF, Schlepper M. Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. PACE 1995; 18: 539-547.
22. Lavergne T, Daubert JC, Chauvin M, Dolla E, Kacet S, Leenhardt A, et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997; 20: 182-188.